New drug, phase 3 study, 100% prevention of HIV.
Published in the New England Journal of Medicine. “No participants receiving twice-yearly lenacapavir acquired HIV infection.” ~ learn more
Published in the New England Journal of Medicine. “No participants receiving twice-yearly lenacapavir acquired HIV infection.” ~ learn more
Published in the New England Journal of Medicine. “No participants receiving twice-yearly lenacapavir acquired HIV infection.” ~ learn more
“The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression measure revealing no significant difference between the two treatments, but a number of secondary measures notably favoring psilocybin.” | learn more
“In 2013, the New England Journal of Medicine published a landmark study that found that people put on a Mediterranean diet had a 30% lower chance of heart attack, stroke, or death from cardiovascular disease than people on a low-fat […]